Research Analysts’ Price Target Changes for May 4th (AEM, ATMU, BSY, CAH, CELH, CHD, CL, CNK, CURB, EL)

Research Analysts’ price target changes for Monday, May 4th:

Agnico Eagle Mines (NYSE:AEM) (TSE:AEM) had its price target increased by JPMorgan Chase & Co. from $220.00 to $222.00. The firm currently has a neutral rating on the stock.

Atmus Filtration Technologies (NYSE:ATMU) had its price target lowered by JPMorgan Chase & Co. from $70.00 to $67.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Bentley Systems (NASDAQ:BSY) had its target price cut by UBS Group AG from $43.00 to $40.00. They currently have a neutral rating on the stock.

Cardinal Health (NYSE:CAH) had its target price reduced by JPMorgan Chase & Co. from $243.00 to $215.00. The firm currently has a neutral rating on the stock.

Celsius (NASDAQ:CELH) had its price target trimmed by JPMorgan Chase & Co. from $77.00 to $67.00. They currently have an overweight rating on the stock.

Church & Dwight (NYSE:CHD) had its price target boosted by JPMorgan Chase & Co. from $98.00 to $99.00. They currently have a neutral rating on the stock.

Colgate-Palmolive (NYSE:CL) had its target price raised by JPMorgan Chase & Co. from $95.00 to $96.00. The firm currently has an overweight rating on the stock.

Cinemark (NYSE:CNK) had its price target boosted by JPMorgan Chase & Co. from $35.00 to $36.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Curbline Properties (NYSE:CURB) had its price target raised by JPMorgan Chase & Co. from $30.00 to $31.00. The firm currently has an overweight rating on the stock.

Estee Lauder Companies (NYSE:EL) had its target price raised by JPMorgan Chase & Co. from $98.00 to $99.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Estee Lauder Companies (NYSE:EL) had its price target increased by UBS Group AG from $75.00 to $85.00. UBS Group AG currently has a neutral rating on the stock.

Eastman Chemical (NYSE:EMN) had its target price increased by JPMorgan Chase & Co. from $80.00 to $82.00. They currently have an overweight rating on the stock.

Federated Hermes (NYSE:FHI) had its price target reduced by JPMorgan Chase & Co. from $56.00 to $53.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.

IAC (NASDAQ:IAC) had its target price increased by JPMorgan Chase & Co. from $46.00 to $52.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Ingram Micro (NYSE:INGM) had its target price boosted by JPMorgan Chase & Co. from $24.00 to $26.00. The firm currently has an underweight rating on the stock.

Lazard (NYSE:LAZ) had its target price lowered by UBS Group AG from $45.00 to $44.00. The firm currently has a neutral rating on the stock.

Linde (NASDAQ:LIN) had its price target raised by JPMorgan Chase & Co. from $525.00 to $530.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Option Care Health (NASDAQ:OPCH) had its target price reduced by JPMorgan Chase & Co. from $40.00 to $33.00. The firm currently has an overweight rating on the stock.

Primoris Services (NYSE:PRIM) had its price target boosted by UBS Group AG from $176.00 to $212.00. The firm currently has a buy rating on the stock.

Primo Brands (NYSE:PRMB) had its target price lowered by JPMorgan Chase & Co. from $27.00 to $26.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Ryan Specialty (NYSE:RYAN) had its target price cut by UBS Group AG from $59.00 to $51.00. UBS Group AG currently has a buy rating on the stock.

Textron (NYSE:TXT) had its price target boosted by JPMorgan Chase & Co. from $90.00 to $105.00. They currently have a neutral rating on the stock.

Willis Towers Watson Public (NASDAQ:WTW) had its target price reduced by UBS Group AG from $409.00 to $400.00. They currently have a buy rating on the stock.